Bexsero (GlaxoSmithKline Biologicals SA)
Welcome to the PulseAid listing for the Bexsero drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Biologicals SA |
| NON-PROPRIETARY NAME: | NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN |
| SUBSTANCE NAME: | NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENIN |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Bexsero VACCINE Details:
| Item Description | Bexsero from GlaxoSmithKline Biologicals SA |
| LABELER NAME: | GlaxoSmithKline Biologicals SA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50; 50; 50; 25(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
| START MARKETING DATE: | 2016-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58160-976_a68650e0-73f3-406a-8d6f-563bebd0b8a1 |
| PRODUCT NDC: | 58160-976 |
| APPLICATION NUMBER: | BLA125546 |
Other NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENIN Pharmaceutical Manufacturers / Labelers:
